Novo Nordisk Logo

Novo Nordisk

Develops treatments for serious chronic diseases like diabetes, obesity, and hemophilia.

NOVO | CO

Overview

Corporate Details

ISIN(s):
DK0062498333 (+1 more)
LEI:
549300DAQ1CVT6CXN342
Country:
Denmark
Address:
Novo Alle 1, 2880 Bagsværd

Description

Novo Nordisk is a global healthcare company dedicated to developing treatments for serious chronic diseases. With over a century of innovation, it is a world leader in diabetes care, providing a comprehensive portfolio of insulin products and GLP-1 receptor agonists. Leveraging its expertise in metabolic conditions, the company has also become a prominent force in obesity management. Novo Nordisk's therapeutic focus extends to other serious chronic conditions, including rare bleeding disorders like hemophilia and growth hormone-related disorders.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-11-25 14:19
FORM 6-K
English ZIP 215.1 KB
2025-11-25 12:24 English HTML 9.7 KB
2025-11-25 12:24 English PDF 123.1 KB
2025-11-24 13:23
FORM 6-K
English ZIP 214.6 KB
2025-11-24 12:20 English PDF 108.1 KB
2025-11-24 12:20 English HTML 9.1 KB
2025-11-17 21:35
FORM 6-K
English ZIP 212.4 KB
2025-11-17 14:58 English HTML 16.2 KB
2025-11-17 14:58 English PDF 123.6 KB
2025-11-14 16:12
FORM 6-K
English ZIP 211.9 KB
2025-11-14 12:00
FORM 6-K
English ZIP 211.4 KB
2025-11-12 12:10
FORM 6-K
English ZIP 213.2 KB
2025-11-11 14:39 English HTML 26.7 KB
2025-11-11 14:39 English PDF 155.6 KB
2025-11-07 12:00
FORM 6-K
English ZIP 211.6 KB

Automate Your Workflow. Get a real-time feed of all Novo Nordisk filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Novo Nordisk

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Novo Nordisk via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.